Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients

Clinical trial NCT05319886 · UNKNOWN

Trial details

NCT number: NCT05319886
Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Status: UNKNOWN
Study type: OBSERVATIONAL

Lung Cancer Lung Carcinoma Non Small Cell Lung Cancer Non-small Cell Carcinoma Lung Neoplasm

Start date: 2022-05-16
Primary completion: 2023-03-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.